» Articles » PMID: 35318963

AKR1D1 Knockout Mice Develop a Sex-dependent Metabolic Phenotype

Abstract

Steroid 5β-reductase (AKR1D1) plays important role in hepatic bile acid synthesis and glucocorticoid clearance. Bile acids and glucocorticoids are potent metabolic regulators, but whether AKR1D1 controls metabolic phenotype in vivo is unknown. Akr1d1-/- mice were generated on a C57BL/6 background. Liquid chromatography/mass spectrometry, metabolomic and transcriptomic approaches were used to determine effects on glucocorticoid and bile acid homeostasis. Metabolic phenotypes including body weight and composition, lipid homeostasis, glucose tolerance and insulin tolerance were evaluated. Molecular changes were assessed by RNA-Seq and Western blotting. Male Akr1d1-/- mice were challenged with a high fat diet (60% kcal from fat) for 20 weeks. Akr1d1-/- mice had a sex-specific metabolic phenotype. At 30 weeks of age, male, but not female, Akr1d1-/- mice were more insulin tolerant and had reduced lipid accumulation in the liver and adipose tissue yet had hypertriglyceridemia and increased intramuscular triacylglycerol. This phenotype was associated with sexually dimorphic changes in bile acid metabolism and composition but without overt effects on circulating glucocorticoid levels or glucocorticoid-regulated gene expression in the liver. Male Akr1d1-/- mice were not protected against diet-induced obesity and insulin resistance. In conclusion, this study shows that AKR1D1 controls bile acid homeostasis in vivo and that altering its activity can affect insulin tolerance and lipid homeostasis in a sex-dependent manner.

Citing Articles

Chronic small intestinal helminth infection perturbs bile acid homeostasis and disrupts bile acid signaling in the murine small intestine.

Lane J, Brosschot T, Gatti D, Gauthier C, Lawrence K, Pluzhnikova V Front Parasitol. 2025; 2():1214136.

PMID: 39816838 PMC: 11731828. DOI: 10.3389/fpara.2023.1214136.


A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liver.

Perry A, Hadad N, Chatterjee E, Jimenez-Ramos M, Farber-Eger E, Roshani R Cell Rep Med. 2024; 5(12):101871.

PMID: 39657669 PMC: 11722105. DOI: 10.1016/j.xcrm.2024.101871.


Efficacy and safety of switching therapy from chenodeoxycholic acid to cholic acid in Japanese patients with bile acid synthesis disorders.

Suzuki M, Takei H, Suzuki H, Mori J, Sugimoto S, Mizuochi T Mol Genet Metab Rep. 2024; 41:101166.

PMID: 39650085 PMC: 11625240. DOI: 10.1016/j.ymgmr.2024.101166.


Bile from the hemojuvelin-deficient mouse model of iron excess is enriched in iron and ferritin.

Prajapati M, Chiu L, Zhang J, Chong G, DaSilva N, Bartnikas T Metallomics. 2024; 16(10).

PMID: 39313333 PMC: 11459263. DOI: 10.1093/mtomcs/mfae043.


5β-Dihydrosteroids: Formation and Properties.

Penning T, Covey D Int J Mol Sci. 2024; 25(16).

PMID: 39201544 PMC: 11354470. DOI: 10.3390/ijms25168857.


References
1.
Kaur A, Patankar J, de Haan W, Ruddle P, Wijesekara N, Groen A . Loss of Cyp8b1 improves glucose homeostasis by increasing GLP-1. Diabetes. 2014; 64(4):1168-79. DOI: 10.2337/db14-0716. View

2.
Rando G, Wahli W . Sex differences in nuclear receptor-regulated liver metabolic pathways. Biochim Biophys Acta. 2011; 1812(8):964-73. DOI: 10.1016/j.bbadis.2010.12.023. View

3.
Upreti R, Hughes K, Livingstone D, Gray C, Minns F, Macfarlane D . 5α-reductase type 1 modulates insulin sensitivity in men. J Clin Endocrinol Metab. 2014; 99(8):E1397-406. PMC: 4207930. DOI: 10.1210/jc.2014-1395. View

4.
Haeusler R, Astiarraga B, Camastra S, Accili D, Ferrannini E . Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids. Diabetes. 2013; 62(12):4184-91. PMC: 3837033. DOI: 10.2337/db13-0639. View

5.
Nikolaou N, Hodson L, Tomlinson J . The role of 5-reduction in physiology and metabolic disease: evidence from cellular, pre-clinical and human studies. J Steroid Biochem Mol Biol. 2021; 207:105808. DOI: 10.1016/j.jsbmb.2021.105808. View